Cargando…

Combined aquaretic and diuretic therapy in acute heart failure

INTRODUCTION: Acute heart failure (AHF) is a leading cause of hospitalization and readmission in the US. The present study evaluated maximum diuresis while minimizing electrolyte imbalances, hemodynamic instability, and kidney dysfunction, to achieve a euvolemic state safely in a shorter period of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goyfman, Michael, Zamudio, Paul, Jang, Kristine, Chee, Jennifer, Miranda, Catherine, Butler, Javed, Wadhwa, Nand K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473484/ https://www.ncbi.nlm.nih.gov/pubmed/28652798 http://dx.doi.org/10.2147/IJNRD.S135660

Ejemplares similares

Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload
por: Jermyn, Rita, et al.
Publicado: (2013)

Urea channel inhibitors (UCIs): A new functional class of aquaretics
por: Knepper, Mark A., et al.
Publicado: (2013)

Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study
por: Uojima, Haruki, et al.
Publicado: (2017)

Diuretic Resistance in Heart Failure
por: Gupta, Richa, et al.
Publicado: (2019)

Congestion and Diuretic Resistance in Acute or Worsening Heart Failure
por: Kristjánsdóttir, Ingibjörg, et al.
Publicado: (2020)

A combined clinical and biomarker approach to predict diuretic response in acute heart failure
por: ter Maaten, Jozine M., et al.
Publicado: (2015)

Diuretics as pathogenetic treatment for heart failure
por: Guglin, Maya
Publicado: (2011)

Optimal diuretic strategies in heart failure
por: Suri, Sarabjeet S., et al.
Publicado: (2021)

Diuretic Resistance Associated With Heart Failure
por: Shams, Elham, et al.
Publicado: (2022)

Decongestion: Diuretics and other therapies for hospitalized heart failure
por: Vazir, Ali, et al.
Publicado: (2016)

Loop Diuretic Administration in Patients with Acute Heart Failure and Reduced Systolic Function: Effects of Different Intravenous Diuretic Doses and Diuretic Response Measurements
por: Ruocco, Gaetano, et al.
Publicado: (2019)

UTILIZING COMBINATION THERAPY WITH INHALED EPOPROSTENOL AND LOOP DIURETICS IN ACUTE HYPOXIC RESPIRATORY FAILURE FROM COVID-19
por: PINO, MARI-ELENA, et al.
Publicado: (2022)

Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney
por: Palazzuoli, Alberto, et al.
Publicado: (2015)

Markers of diuretic resistance in emergency department patients with acute heart failure
por: Doering, Andrew, et al.
Publicado: (2017)

Worsening renal function in acute heart failure in the context of diuretic response
por: Emmens, Johanna E., et al.
Publicado: (2021)

Role of Diuretics and Ultrafiltration in Congestive Heart Failure
por: Shchekochikhin, Dmitry, et al.
Publicado: (2013)

The Diuretic Effect of Theocalcin in Congestive Heart Failure
Publicado: (1931)

Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial
por: ter Maaten, Jozine M., et al.
Publicado: (2023)

Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2022)

Association between changes in loop diuretic dose and outcomes in acute heart failure
por: Seko, Yuta, et al.
Publicado: (2023)

Spot Urinary Sodium as a Biomarker of Diuretic Response in Acute Heart Failure
por: Oliva‐Damaso, Nestor, et al.
Publicado: (2023)

Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016)

Diuretic dosing in heart failure: more data are needed
por: De Vecchis, Renato, et al.
Publicado: (2018)

Diuretics in the management of chronic heart failure: when and how
por: Magdy, Joseph S, et al.
Publicado: (2022)

The Importance of the Nephrologist in the Treatment of the Diuretic-Resistant Heart Failure
por: Pethő, Ákos Géza, et al.
Publicado: (2023)

The Efficacy, the Treatment Response and the Aquaretic Effects of a Three-Year Tolvaptan Regimen in Polycystic Kidney Disease Patients
por: Gkika, Vasiliki, et al.
Publicado: (2023)

Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure
por: Ikeda, Shuntaro, et al.
Publicado: (2017)

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction
por: Matsue, Yuya, et al.
Publicado: (2017)

Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study
por: Dauw, Jeroen, et al.
Publicado: (2021)

Activity of the adrenomedullin system to personalise post-discharge diuretic treatment in acute heart failure
por: Kozhuharov, Nikola, et al.
Publicado: (2021)

Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome
por: Qavi, Ahmed Hassaan, et al.
Publicado: (2015)

Effects of Empagliflozin on Diuretics Reduction in Outpatient Heart Failure Patients
por: Kim, Soo-Jin, et al.
Publicado: (2022)

Toward quantification of loop diuretic responsiveness for congestive heart failure
por: Oyama, Mark A., et al.
Publicado: (2022)

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
por: Yeoh, Su Ern, et al.
Publicado: (2023)

Sodium glucose cotransporter 2 inhibitors as diuretic adjuvants in acute decompensated heart failure: a case series
por: Griffin, Matthew, et al.
Publicado: (2020)

The Potential Role of Torsemide in Optimizing Loop Diuretic Therapy for Heart Failure Patients
por: Chopra, V. K, et al.
Publicado: (2023)

Renin-Angiotensin-Aldosterone System Activation and Diuretic Response in Ambulatory Patients With Heart Failure
por: Amatruda, Jonathan G., et al.
Publicado: (2022)

Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR‐AHF
por: Palazzuoli, Alberto, et al.
Publicado: (2017)

Renoprotective Benefit of Tolvaptan in Acute Decompensated Heart Failure Patients With Loop Diuretic-Resistant Status
por: Yamamoto, Tomohiko, et al.
Publicado: (2019)

The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality
por: Iqbal, Arshad Muhammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3a8fq2qsgaun9a67kktlror64k